Abstract
A 79-year-old man with a recent diagnosis of acute myeloblastic leukemia received induction chemotherapy with daunorubicin and cytarabine, plus moxifloxacin and fluconazole prophylaxis. Approximately 2 weeks later, an asymptomatic eruption appeared on his trunk. He then developed a neutropenic fever and was started on aztreonam, vancomycin, voriconazole, and amikacin and was transferred to our facility from an outside hospital. Micafungin was subsequently added, and the patient defervesced within a few days.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 483-484 |
| Number of pages | 2 |
| Journal | SKINmed |
| Volume | 15 |
| Issue number | 6 |
| State | Published - Nov 1 2017 |
Bibliographical note
Publisher Copyright:© 2017 Pulse Marketing & Communications, LLC.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Role of immune status in chemotherapy-induced transient acantholytic dermatosis'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS